Exploring ginseng's potential role as an adjuvant therapy in COVID-19

Author:

Aielli Lisa1,Shahzadi Chman23,Costantini Erica4

Affiliation:

1. Department of Innovative Technologies in Medicine and Dentistry, University “G. d'Annunzio” of Chieti-Pescara, Italy

2. Center of Advanced Studies and Technology (CAST), University “G. d'Annunzio” of Chieti-Pescara, Italy

3. University School for Advanced Studies IUSS Pavia, Italy

4. Department of Medicine and Science of Aging, University “G. d'Annunzio” of Chieti-Pescara, Italy

Abstract

<abstract> <p>Ginseng is a plant from the Panax genus used since ancient times as a prominent component of traditional Chinese medicine, and is prized for its energizing, antiaging and antioxidant properties. Over time, the scientific community has taken a keen interest in ginseng's potential as a supplement in various health sectors. While there is a substantial body of data demonstrating the effectiveness of ginseng and other natural products as adjuncts in the treatment of respiratory diseases, the emergence of the COVID-19 pandemic has amplified the attention on ginseng and its extracts as potential antiviral and antibacterial agents. This review aims to summarize the potential benefits of ginseng in the prevention of COVID-19, the alleviation of symptoms and the enhancement of clinical outcomes for patients. It suggests incorporating ginseng and other natural compounds into complementary therapeutic regimens to augment the effectiveness of vaccines and pharmacological treatments. However, it's important to note that further experiments and clinical studies are necessary to solidify the efficacy of ginseng against COVID-19 and to establish its use as a viable option.</p> </abstract>

Publisher

American Institute of Mathematical Sciences (AIMS)

Subject

General Engineering,Energy Engineering and Power Technology

Reference123 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3